BASTA STEVEN L (President and CEO) received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/12/2026ACC: 0001193125-26-048867
DirectorOfficer· President and CEO
Since Feb 2026
+6.08K
Net shares
Net buyer
$80.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
12.36K acquired · 6.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+12.36K
Price / share
—
Trade value
—
% of position
3.4%
2/10/2026
367.23K→379.59K
Common Stock
Direct
Shares
−6.28K
Price / share
$12.82
Trade value
$80.47K
% of position
1.7%
2/10/2026
379.59K→373.31K
Total
Net shares
+6.08K
Net value
-$80.47K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | A · Award | +12.36K | — | — | 3.4% | 367.23K | 379.59K |
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −6.28K | $12.82 | $80.47K | 1.7% | 379.59K | 373.31K |
| Total | +6.08K | -$80.47K | ||||||
Derivative Transactions0
No derivative transactions reported